Table 1 Comparison of basic clinical data of patients in obstructive CAD group, CMD group and control group
Parameters | obstructive CAD group (n = 67) | CMD group (n = 67) | control group (n = 108) | P value |
|---|---|---|---|---|
Age (years old) | 62.8 ± 9.0 | 64.9 ± 8.4 | 60.9 ± 7.4 | 0.007** |
Male, n (%) | 46 (68.7) | 16 (23.9) | 40 (37.0) | 0.000** |
BMI, kg/m2 | 25.3 ± 2.9 | 24.5 ± 3.2 | 25.1 ± 3.2 | 0.301 |
Hypertension, n (%) | 43 (64.2) | 48 (71.6) | 60 (55.6) | 0.096 |
diabetes mellitus, n (%) | 25 (37.3) | 12 (17.9) | 19 (17.6) | 0.005** |
Dyslipidemia, n (%) | 39 (58.2) | 45 (67.2) | 53 (49.1) | 0.061 |
Smoke, n (%) | 26 (41.9) | 11 (19.0) | 23 (20.9) | 0.006** |
HR, times/min | 65.0 ± 8.5 | 65.2 ± 10.0 | 64.7 ± 7.7 | 0.917 |
SBP, mmHg | 132.8 ± 14.4 | 132.4 ± 13.5 | 130.5 ± 13.0 | 0.473 |
DBP, mmHg | 75.4 ± 10.7 | 73.4 ± 9.5 | 75.6 ± 9.1 | 0.311 |
antiplatelet drugs, n (%) | 65 (97.0) | 56 (83.6) | 76 (70.4) | 0.000** |
Statin drugs, n (%) | 60 (90.0) | 55 (82.1) | 80 (74.1) | 0.030* |
ACEI/ARB, n (%) | 20 (30.0) | 27 (40.3) | 34 (31.5) | 0.311 |
β-blockers, n (%) | 33 (49.3) | 24 (35.8) | 40 (37.0) | 0.247 |
CCB, n(%) | 23 (34.3) | 27 (40.3) | 30 (27.8) | 0.201 |